- Home
- ZBAI vs CUTR Comparison
ZBAI vs CUTR Comparison
Compare ZBAI & CUTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAI
- CUTR
- Stock Information
- Founded
- ZBAI 2015
- CUTR 1988
- Country
- ZBAI United States
- CUTR United States
- Employees
- ZBAI N/A
- CUTR N/A
- Industry
- ZBAI Professional Services
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZBAI Consumer Discretionary
- CUTR Health Care
- Exchange
- ZBAI Nasdaq
- CUTR Nasdaq
- Market Cap
- ZBAI 9.9M
- CUTR 9.2M
- IPO Year
- ZBAI N/A
- CUTR 2004
- Fundamental
- Price
- ZBAI $1.52
- CUTR $0.47
- Analyst Decision
- ZBAI
- CUTR Hold
- Analyst Count
- ZBAI 0
- CUTR 3
- Target Price
- ZBAI N/A
- CUTR $3.00
- AVG Volume (30 Days)
- ZBAI 115.6K
- CUTR 1.6M
- Earning Date
- ZBAI 03-17-2025
- CUTR 03-20-2025
- Dividend Yield
- ZBAI N/A
- CUTR N/A
- EPS Growth
- ZBAI N/A
- CUTR N/A
- EPS
- ZBAI N/A
- CUTR N/A
- Revenue
- ZBAI $495,000.00
- CUTR $155,210,000.00
- Revenue This Year
- ZBAI N/A
- CUTR N/A
- Revenue Next Year
- ZBAI N/A
- CUTR $4.61
- P/E Ratio
- ZBAI N/A
- CUTR N/A
- Revenue Growth
- ZBAI N/A
- CUTR N/A
- 52 Week Low
- ZBAI $0.58
- CUTR $0.28
- 52 Week High
- ZBAI $2.50
- CUTR $3.18
- Technical
- Relative Strength Index (RSI)
- ZBAI N/A
- CUTR 54.47
- Support Level
- ZBAI N/A
- CUTR $0.36
- Resistance Level
- ZBAI N/A
- CUTR $0.50
- Average True Range (ATR)
- ZBAI 0.00
- CUTR 0.11
- MACD
- ZBAI 0.00
- CUTR 0.01
- Stochastic Oscillator
- ZBAI 0.00
- CUTR 20.16
About CUTR Cutera Inc.
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.